(Q39478326)

12 September 2017

Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia (English)

1 reference

12 September 2017

1 reference

Susanna Hegewisch-Becker

11

object named as

Susanna Hegewisch-Becker

0 references

Uwe Platzbecker

13

object named as

Uwe Platzbecker

1 reference

12 September 2017

16

Carsten Bokemeyer

1 reference

12 September 2017

Djordje Atanackovic

1

1 reference

12 September 2017

Tim Luetkens

2

1 reference

12 September 2017

Benjamin Kloth

3

1 reference

12 September 2017

Gregor Fuchs

4

1 reference

12 September 2017

Yanran Cao

5

1 reference

12 September 2017

York Hildebrandt

6

1 reference

12 September 2017

Sabrina Meyer

7

1 reference

12 September 2017

Katrin Bartels

8

1 reference

12 September 2017

Henrike Reinhard

9

1 reference

12 September 2017

Nesrine Lajmi

10

1 reference

12 September 2017

Susanna Hegewisch-Becker

11

1 reference

12 September 2017

Georgia Schilling

12

1 reference

12 September 2017

Guido Kobbe

14

1 reference

12 September 2017

Thomas Schroeder

15

1 reference

12 September 2017

Nicolaus Kröger

17

1 reference

12 September 2017

2 September 2011

1 reference

American Journal of Hematology

12 September 2017

1 reference

12 September 2017

86

1 reference

12 September 2017

11

1 reference

12 September 2017

918-922

1 reference

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

12 September 2017

1 reference

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

21 January 2018

1 reference

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

21 January 2018

1 reference

Genome-wide analysis of cancer/testis gene expression

21 January 2018

1 reference

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

21 January 2018

1 reference

Concise review: cancer/testis antigens, stem cells, and cancer.

21 January 2018

1 reference

Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.

21 January 2018

1 reference

Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia

21 January 2018

1 reference

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

21 January 2018

1 reference

Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells

21 January 2018

1 reference

Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view

21 January 2018

1 reference

Clinical development of histone deacetylase inhibitors as anticancer agents

21 January 2018

1 reference

Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia

21 January 2018

1 reference

Expression of serologically identified tumor antigens in acute leukemias.

21 January 2018

1 reference

Expression of testicular genes in haematological malignancies

21 January 2018

1 reference

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

21 January 2018

1 reference

Simultaneous expression of different immunogenic antigens in acute myeloid leukemia

21 January 2018

1 reference

A tumour-associated antigen expression in human haematological malignancies.

21 January 2018

1 reference

A yeast two-hybrid system using Sp17 identified Ropporin as a novel cancer-testis antigen in hematologic malignancies

21 January 2018

1 reference

The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies

21 January 2018

1 reference

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

21 January 2018

1 reference

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.

21 January 2018

1 reference

Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia

21 January 2018

1 reference

Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia

21 January 2018

1 reference

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.

21 January 2018

1 reference

Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia

21 January 2018

1 reference

Current status of epigenetic treatment in myelodysplastic syndromes

21 January 2018

1 reference

Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents

21 January 2018

1 reference

The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells

21 January 2018

1 reference

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.22141

1 reference

release_lhny5hanfngmbft2x6tklcuffa

12 September 2017

0 references

1 reference